HopeStage
Back to all studies
RecruitingNCT06200155

Psilocybin-assisted therapy or placebo for anxiety and depression in advanced cancer

About this titleRead the official source — NCT06200155
Medication studyAges 25+United States
The study in practice

Understand this study

Who could participate?

Listed age limits: from 25 years.

Listed locations
HoustonSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 16, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
48
Sponsor
M.D. Anderson Cancer Center
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
Over 25 Years
Official registry ID
NCT06200155
Official title
Show the full official title

TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

Recruitment & locations

Currently recruiting

Houston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is M.D. Anderson Cancer Center.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin.

Who can participate?

Listed age limits: from 25 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies